Kraig Biocraft Laboratories Poised for Explosive Spider Silk Production Growth

Got story updates? Submit your updates here. ›

Kraig Biocraft Laboratories, a leading developer of genetically engineered spider silk-based fiber technologies, has announced its 2026 production plan that will drive explosive growth and establish a new global benchmark for spider silk manufacturing. The company's technology, built upon the use of modified silkworms, will begin large-scale deployment of its proprietary spider silk silkworm eggs within the next 30 days, with production expected to ramp up rapidly to 10 metric tons of recombinant spider silk cocoon per month by May.

Why it matters

This level of sustained spider silk output represents a scale that has never been seen before, firmly positioning Kraig Labs as the world leader in this field. The company's commitment to sustaining this operational capacity and plans for adding even more production capacity later in 2026 demonstrate its ambition to transform the commercialization of spider silk technology.

The details

Kraig Labs has engineered and refined proprietary production strains designed for durability, consistency, and high yields of recombinant spider silk. The company has also made substantial investments in facilities, workforce expansion, and vertically integrated production infrastructure to create a manufacturing platform built for scale and execution.

• Within the next 30 days, the Company will begin large-scale deployment of its stockpile of proprietary spider silk silkworm eggs.
• Production is scheduled to begin the first week of March.
• Kraig Labs is expected to hit full output of 10 metric tons of recombinant spider silk cocoon per month by May.

What they’re saying

What’s next

Kraig Labs has plans for adding even more production capacity later in 2026 to sustain its operational capacity.